These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 35063123)

  • 61. Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections.
    Abu-Raddad LJ; Chemaitelly H; Ayoub HH; Tang P; Coyle P; Hasan MR; Yassine HM; Benslimane FM; Al-Khatib HA; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Khal A; Al-Thani MH; Bertollini R
    Nat Commun; 2022 Jan; 13(1):532. PubMed ID: 35087035
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021.
    Tenforde MW; Patel MM; Gaglani M; Ginde AA; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Duggal A; Wilson JG; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Botros M; Lauring AS; Shapiro NI; Halasa N; Chappell JD; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Naioti EA; Adams K; Lewis NM; Surie D; McMorrow ML; Self WH;
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):118-124. PubMed ID: 35085218
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Novavax Heterologous Coronavirus Disease 2019 Booster Demonstrates Lower Reactogenicity Than Messenger RNA: A Targeted Review.
    Marchese AM; Rousculp M; Macbeth J; Beyhaghi H; Seet BT; Toback S
    J Infect Dis; 2024 Aug; 230(2):e496-e502. PubMed ID: 37992183
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection.
    Liu B; Stepien S; Qian J; Gidding H; Nicolopoulos K; Amin J; Cheng A; Macartney K
    Vaccine; 2023 Aug; 41(38):5587-5591. PubMed ID: 37524631
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
    JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Audio Interview: Waning Immunity against SARS-CoV-2.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Dec; 385(24):e99. PubMed ID: 34879456
    [No Abstract]   [Full Text] [Related]  

  • 67. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    Normark J; Vikström L; Gwon YD; Persson IL; Edin A; Björsell T; Dernstedt A; Christ W; Tevell S; Evander M; Klingström J; Ahlm C; Forsell M
    N Engl J Med; 2021 Sep; 385(11):1049-1051. PubMed ID: 34260850
    [No Abstract]   [Full Text] [Related]  

  • 68. Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients.
    Mulhern JG; Fadia A; Patel R; Ficociello LH; Willetts J; Dahne-Steuber IA; Pollan MC; Mullon C; DeLisi J; Johnson C; Mysayphonh C; Kossmann RJ; Anger MS; Hymes JL
    Clin J Am Soc Nephrol; 2021 Nov; 16(11):1720-1722. PubMed ID: 34312162
    [No Abstract]   [Full Text] [Related]  

  • 69. COVID-19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis.
    Garcia P; Anand S; Han J; Montez-Rath ME; Sun S; Shang T; Parsonnet J; Chertow GM; Schiller B; Abra G
    J Am Soc Nephrol; 2022 Jan; 33(1):33-37. PubMed ID: 34645698
    [No Abstract]   [Full Text] [Related]  

  • 70. Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.
    Servellita V; Morris MK; Sotomayor-Gonzalez A; Gliwa AS; Torres E; Brazer N; Zhou A; Hernandez KT; Sankaran M; Wang B; Wong D; Wang C; Zhang Y; Reyes KR; Glasner D; Deng X; Streithorst J; Miller S; Frias E; Rodgers M; Cloherty G; Hackett J; Hanson C; Wadford D; Philip S; Topper S; Sachdev D; Chiu CY
    Nat Microbiol; 2022 Feb; 7(2):277-288. PubMed ID: 35013591
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination.
    Paniskaki K; Anft M; Meister TL; Marheinecke C; Pfaender S; Skrzypczyk S; Seibert FS; Thieme CJ; Konik MJ; Dolff S; Anastasiou O; Holzer B; Dittmer U; Queren C; Fricke L; Rohn H; Westhoff TH; Witzke O; Stervbo U; Roch T; Babel N
    Front Immunol; 2022; 13():816220. PubMed ID: 35145522
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India.
    Singh UB; Rophina M; Chaudhry R; Senthivel V; Bala K; Bhoyar RC; Jolly B; Jamshed N; Imran M; Gupta R; Aggarwal P; Divakar MK; Sinha S; Arvinden VR; Bajaj A; Shamnath A; Jain A; ; Scaria V; Sivasubbu S; Guleria R
    J Med Virol; 2022 Apr; 94(4):1696-1700. PubMed ID: 34786733
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of antibody responses after the 1st and 2nd doses of COVID-19 vaccine with those of patients with mild or severe COVID-19.
    Cha HH; Lim SY; Kwon JS; Kim JY; Bae S; Jung J; Kim SH
    Korean J Intern Med; 2022 Mar; 37(2):455-459. PubMed ID: 35272444
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of vaccine effectiveness of mRNA COVID-19 vaccines in children: a systematic review and meta-analysis.
    Hu YH; Ding Y; Li LW; Cheng J; Cai YH
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2584-2592. PubMed ID: 38567617
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Response to mRNA vaccination for COVID-19 among patients with multiple myeloma.
    Stampfer SD; Goldwater MS; Jew S; Bujarski S; Regidor B; Daniely D; Chen H; Xu N; Li M; Green T; Fung E; Aquino E; Swift R; Eshaghian S; Preugschat K; Feinstein AJ; Spektor TM; Berenson JR
    Leukemia; 2021 Dec; 35(12):3534-3541. PubMed ID: 34326466
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial.
    Zhang B; Fong Y; Fintzi J; Chu E; Janes HE; Kenny A; Carone M; Benkeser D; van der Laan LWP; Deng W; Zhou H; Wang X; Lu Y; Yu C; Borate B; Chen H; Reeder I; Carpp LN; Houchens CR; Martins K; Jayashankar L; Huynh C; Fichtenbaum CJ; Kalams S; Gay CL; Andrasik MP; Kublin JG; Corey L; Neuzil KM; Priddy F; Das R; Girard B; El Sahly HM; Baden LR; Jones T; Donis RO; Koup RA; Gilbert PB; Follmann D; ; ; ;
    Nat Commun; 2024 Sep; 15(1):7954. PubMed ID: 39261482
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mixing vaccines may boost immune responses.
    Vogel G
    Science; 2021 Jun; 372(6547):1138. PubMed ID: 34112673
    [No Abstract]   [Full Text] [Related]  

  • 79. COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis.
    Bilotta C; Perrone G; Adelfio V; Spatola GF; Uzzo ML; Argo A; Zerbo S
    Front Immunol; 2021; 12():729251. PubMed ID: 34912330
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
    Hall VG; Ferreira VH; Ku T; Ierullo M; Majchrzak-Kita B; Chaparro C; Selzner N; Schiff J; McDonald M; Tomlinson G; Kulasingam V; Kumar D; Humar A
    N Engl J Med; 2021 Sep; 385(13):1244-1246. PubMed ID: 34379917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.